Eledon Pharmaceuticals, Inc. (ELDN) vs Invivyd, Inc. (IVVD)

Eledon Pharmaceuticals, Inc. and Invivyd, Inc. are both Biotechnology companies. Eledon Pharmaceuticals, Inc. and Invivyd, Inc. are of similar size ($190.4M and $190.2M). Eledon Pharmaceuticals, Inc. has the higher net margin (0.00% vs −183.9%) and the higher return on invested capital (0.00% vs −334.9%). Across the 13 metrics below, Eledon Pharmaceuticals, Inc. leads on 8 and Invivyd, Inc. on 5.

Valuation

Metric ELDN IVVD Biotechnology median
P/E n/m n/m 8.42
P/S n/m 3.68 10.01
P/B 7.81 1.19 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales n/m 0.94 9.41
Earnings yield (40.09%) (49.25%) (31.85%)
Free cash flow yield (28.62%) (51.08%) (24.58%)

Profitability

Metric ELDN IVVD Biotechnology median
Gross margin 0.00% 92.23% 65.16%
Operating margin 0.00% (192.81%) 0.00%
Net margin 0.00% (183.90%) 0.00%
Free cash flow margin 0.00% (187.88%) 0.00%
Return on equity (236.51%) (95.89%) (56.36%)
Return on assets (72.74%) (69.69%) (48.04%)
Return on invested capital 0.00% (334.92%) 0.00%

Growth

Metric ELDN IVVD Biotechnology median
Revenue growth (TTM) — 26.30% 6.02%
EPS growth (last fiscal year) 30.67% 79.02% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELDN IVVD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.90 5.87 4.72
Net debt to EBITDA 1.60 4.24 0.96

Dividend

Metric ELDN IVVD Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ELDN IVVD Biotechnology median
Market cap 190.15m 190.41m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack